The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
Open accessAbstract
IntroductionPhotodynamic therapy (PDT) is a two-step treatment involving the administration of a photosensitive agent followed by its activation at a specific light wavelength for targeting of tumor cells.Materials/MethodsA comprehensive review of the literature was performed to analyze the indications for PDT, mechanisms of action, use of different photosensitizers, the immunomodulatory effects of PDT, and both preclinical and clinical studies for use in high-grade gliomas (HGGs).ResultsPDT has been approved by the United States Food and Drug Administration (FDA) for the treatment of premalignant and malignant diseases, such as actinic keratoses, Barrett’s esophagus, esophageal cancers, and endobronchial non-small cell lung cancers, as well as for the treatment of choroidal neovascularization. In neuro-oncology, clinical trials are currently underway to demonstrate PDT efficacy against a number of malignancies that include HGGs and other brain tumors. Both photosensitizers and photosensitizing precursors have been used for PDT. 5-aminolevulinic acid (5-ALA), an intermediate in the heme synthesis pathway, is a photosensitizing precursor with FDA approval for PDT of actinic keratosis and as an intraoperative imaging agent for fluorescence-guided visualization of malignant tissue during glioma surgery. New trials are underway to utilize 5-ALA as a therapeutic agent for PDT of the intraoperative resection cavity and interstitial PDT for inoperable HGGs.ConclusionPDT remains a promising therapeutic approach that requires further study in HGGs. Use of 5-ALA PDT permits selective tumor targeting due to the intracellular metabolism of 5-ALA. The immunomodulatory effects of PDT further strengthen its use for treatment of HGGs and requires a better understanding. The combination of PDT with adjuvant therapies for HGGs will need to be studied in randomized, controlled studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Gomer, C. J. (1988) · Cited by 4,174
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423 · cited 16×
“Delayed mean tumor progression (8.6 vs. 4.8 months) and increased mean survival (52.8 vs. 24.6 weeks) was observed in GBM patients treated with FGS followed by PDT compared to patients who did not receive PDT after conventional surgery.”
BackgroundResultInfluentialPhotodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Castano, A. P., Demidova, T. N., & Hamblin, M. R. (2004) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00007-4 · Cited by 2,052
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,800
Ostrom, Q. T., Gittleman, H., Xu, J., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now207 · Cited by 1,204
Photophysics and photochemistry of photodynamic therapy: fundamental aspects
Plaetzer, K., Krammer, B., Berlanda, J., Berr, F., & Kiesslich, T. (2009) · Lasers in Medical Science · doi:10.1007/s10103-008-0539-1 · Cited by 891
Dye Sensitizers for Photodynamic Therapy
Ormond, A., & Freeman, H. (2013) · Materials · doi:10.3390/ma6030817 · Cited by 847
Castano, A. P., Demidova, T. N., & Hamblin, M. R. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00030-x · Cited by 767
Cell Death Pathways in Photodynamic Therapy of Cancer
Mroz, P., Yaroslavsky, A., Kharkwal, G. B., & Hamblin, M. R. (2011) · Cancers · doi:10.3390/cancers3022516 · Cited by 704
Porphyrin photosensitizers in photodynamic therapy and its applications
Kou, J., Dou, D., & Yang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.20189 · Cited by 590
An updated overview on the development of new photosensitizers for anticancer photodynamic therapy
Zhang, J., Jiang, C., Figueiró Longo, J. P., Azevedo, R. B., Zhang, H., & Muehlmann, L. A. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.09.003 · Cited by 574
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y.-E. L., Woolliscroft, M. J., Sugai, J. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0946 · Cited by 491
Mallidi, S., Anbil, S., Bulin, A.-L., Obaid, G., Ichikawa, M., & Hasan, T. (2016) · Theranostics · doi:10.7150/thno.16183 · Cited by 449
Hadjipanayis, C. G., Widhalm, G., & Stummer, W. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000929 · Cited by 369
Self-citationA HISTORY OF PHOTODYNAMIC THERAPY
Daniell, M. D., & Hill, J. S. (1991) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1991.tb00230.x · Cited by 341
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
Garg, A. D., Nowis, D., Golab, J., & Agostinis, P. (2010) · Apoptosis · doi:10.1007/s10495-010-0479-7 · Cited by 297
Eljamel, M. S., Goodman, C., & Moseley, H. (2008) · Lasers in Medical Science · doi:10.1007/s10103-007-0494-2 · Cited by 278
Stummer, W., Stocker, S., Novotny, A., Heimann, A., Sauer, O., Kempski, O., Plesnila, N., Wietzorrek, J., & Reulen, H. J. (1998) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(98)00176-6 · Cited by 252
5‐ALA in the management of malignant glioma
Stepp, H., & Stummer, W. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22933 · Cited by 234
Self-citationHistory of Photodynamic Therapy
Abdel-Kader, M. H. (2014) · Photodynamic Therapy · doi:10.1007/978-3-642-39629-8_1 · Cited by 231
Photodynamic therapy: novel third‐generation photosensitizers one step closer?
Josefsen, L. B., & Boyle, R. W. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.98 · Cited by 229
Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?
Quirk, B. J., Brandal, G., Donlon, S., Vera, J. C., Mang, T. S., Foy, A. B., Lew, S. M., Girotti, A. W., Jogal, S., LaViolette, P. S., et al. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.04.009 · Cited by 206
Beck, T. J., Kreth, F. W., Beyer, W., Mehrkens, J. H., Obermeier, A., Stepp, H., Stummer, W., & Baumgartner, R. (2007) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20507 · Cited by 203
Self-citationKessel, D. (2019) · Photochemistry and Photobiology · doi:10.1111/php.12952 · Cited by 203
Interstitial Photodynamic Therapy—A Focused Review
Shafirstein, G., Bellnier, D., Oakley, E., Hamilton, S., Potasek, M., Beeson, K., & Parilov, E. (2017) · Cancers · doi:10.3390/cancers9020012 · Cited by 190
Side Effects and Photosensitization of Human Tissues after Aminolevulinic Acid
Webber, J., Kessel, D., & Fromm, D. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5004 · Cited by 189
Tsai, Y.-C., Vijayaraghavan, P., Chiang, W.-H., Chen, H.-H., Liu, T.-I., Shen, M.-Y., Omoto, A., Kamimura, M., Soga, K., & Chiu, H.-C. (2018) · Theranostics · doi:10.7150/thno.22482 · Cited by 183
Teng, L., Nakada, M., Zhao, S.-G., Endo, Y., Furuyama, N., Nambu, E., Pyko, I. V., Hayashi, Y., & Hamada, J.-I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.12 · Cited by 172
Senders, J. T., Muskens, I. S., Schnoor, R., Karhade, A. V., Cote, D. J., Smith, T. R., & Broekman, M. L. D. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-016-3028-5 · Cited by 161
Photodynamic Therapy for Malignant Brain Tumors
Akimoto, J. (2016) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2015-0296 · Cited by 154
Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer
Meyers, J. D., Cheng, Y., Broome, A., Agnes, R. S., SCHLUCHTER, M. D., Margevicius, S. P., Wang, X., Kenney, M. E., Burda, C., & Basilion, J. P. (2014) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201400119 · Cited by 153
Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies
Béchet, D., Mordon, S. R., Guillemin, F. H., & Barberi‐Heyob, M. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.004 · Cited by 145
Fluorescence-guided resections of malignant gliomas—An Overview
Stummer, W., Reulen, H. J., Novotny, A., Steppe, H., & Tonn, J. C. (2003) · Local Therapies for Glioma Present Status and Future Developments · doi:10.1007/978-3-7091-6090-9_3 · Cited by 128
Wang, H.-W., Zhu, T. C., Putt, M., Solonenko, M. G., Metz, J. M., Dimofte, A., Miles, J. D., Fraker, D. L., GLATSTEIN, E. J., Hahn, S. M., et al. (2005) · Journal of Biomedical Optics · doi:10.1117/1.1854679 · Cited by 124
Johansson, A., Faber, F., Kniebühler, G., Stepp, H. G., Sroka, R. C., Egensperger, R., Beyer, W., & Kreth, F.-W. (2013) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22126 · Cited by 123
Self-citationValdes, P. A., Bekelis, K., Harris, B. T., Wilson, B. C., Leblond, F., Kim, A., Simmons, N. E., Erkmen, K., Paulsen, K. D., & Roberts, D. W. (2013) · Operative Neurosurgery · doi:10.1227/neu.0000000000000117 · Cited by 111
Anzengruber, F., Avci, P., de Freitas, L. F., & Hamblin, M. R. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00455h · Cited by 102
Dupont, C., Vermandel, M., Leroy, H., Quidet, M., Lecomte, F., Delhem, N., Mordon, S. R., & Reyns, N. (2018) · Neurosurgery · doi:10.1093/neuros/nyy324 · Cited by 102
Chung, I. W. H., & Eljamel, S. (2013) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2013.03.007 · Cited by 100
Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid
Olzowy, B., Hundt, C., Stocker, S., Bise, K., Reulen, H. J., & Stummer, W. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.4.0970 · Cited by 97
Rosenthal, M. A., Kavar, B., Hill, J. S., Morgan, D. J., Nation, R. L., Stylli, S. S., Basser, R. L., Uren, S., Geldard, H., Green, M. D., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.519 · Cited by 96
5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma
Coupienne, I., Fettweis, G., Rubio, N., Agostinis, P., & Piette, J. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05213f · Cited by 91
Fluorescence‐guided surgery for high‐grade gliomas
Lakomkin, N., & Hadjipanayis, C. G. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25154 · Cited by 91
Self-citationBellnier, D. A., Greco, W. R., Loewen, G., Nava, H., Oseroff, A. R., & Dougherty, T. J. (2006) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20340 · Cited by 89
Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma
Rajora, M. A., Ding, L., Valic, M. S., Jiang, W., Overchuk, M., Chen, J., & Zheng, G. (2017) · Chemical Science · doi:10.1039/c7sc00732a · Cited by 88
Stables, G. I., & Ash, D. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90035-7 · Cited by 84
Coupienne, I., Bontems, S., Dewaele, M., Rubio, N., Habraken, Y., Fulda, S., Agostinis, P., & Piette, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.015 · Cited by 83
Etminan, N., Peters, C., Lakbir, D., Bünemann, E., Börger, V., Sabel, M., Hänggi, D., Steiger, H. J., Stummer, W., & Sorg, R. V. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.327 · Cited by 82
Stereotactic Laser Interstitial Thermal Therapy for Recurrent High-Grade Gliomas
Lee, I. Y., Kalkanis, S. N., & Hadjipanayis, C. G. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001443 · Cited by 80
Self-citationTétard, M.-C., Vermandel, M., Mordon, S. R., Lejeune, J.-P., & Reyns, N. (2014) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2014.04.004 · Cited by 75
Wang, W., Tabu, K., Hagiya, Y., Sugiyama, Y., Kokubu, Y., Murota, Y., Ogura, S., & Taga, T. (2017) · Scientific Reports · doi:10.1038/srep42070 · Cited by 70
Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors
Krishnamurthy, S., Powers, S. K., Witmer, P., & Brown, T. (2000) · Lasers in Surgery and Medicine · Cited by 69
Photodynamic Therapy of Malignant Brain Tumours: A phase III trial
Kostron, H., Fritsch, E., & Grunert, V. (1988) · British Journal of Neurosurgery · doi:10.3109/02688698808992675 · Cited by 69
Karmakar, S., Banik, N. L., Patel, S. J., & Ray, S. K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.071 · Cited by 68
Fighting fire with fire: the revival of thermotherapy for gliomas.
Titsworth, W. L., Murad, G. J. A., Hoh, B. L., & Rahman, M. (2014) · PubMed · Cited by 67
Busch, T. M., Xing, X., Yu, G., Yodh, A. G., Wileyto, E. P., Wang, H. W., Durduran, T., Zhu, T. C., & Wang, K. K. H. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b9pp00004f · Cited by 67
Self-citationDong, X., Noorbakhsh, A., Hirshman, B. R., Zhou, T., Tang, J. A., Chang, D. C., Carter, B. S., & Chen, C. C. (2015) · Neuro-Oncology Practice · doi:10.1093/nop/npv016 · Cited by 65
Béchet, D., Auger, F., Couleaud, P., Marty, E., Ravasi, L., Durieux, N., Bonnet, C., Plénat, F., Frochot, C., Mordon, S. R., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.007 · Cited by 64
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
Kaneko, S., & Kaneko, S. (2016) · International Journal of Biomedical Imaging · doi:10.1155/2016/6135293 · Cited by 64
Photodynamic opening of blood-brain barrier
SEMYACHKINA-GLUSHKOVSKAYA, O. V., Kurths, J., Borisova, E. G., Sokolovski, S. G., Mantareva, V. N., Ангелов, И., Shirokov, A. A., Наволокин, Н. А., Shushunova, N. A., Khorovodov, A. P., et al. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.005040 · Cited by 61
Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier
Grabb, P. A., & Gilbert, M. R. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.6.1053 · Cited by 56
Yang, X., Li, W., Palasuberniam, P., Myers, K. A., Wang, C., & Chen, B. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12454 · Cited by 55
Madsen, S. J., Sun, C., Tromberg, B. J., & Hirschberg, H. (2001) · Lasers in Surgery and Medicine · doi:10.1002/lsm.10005 · Cited by 54
Combination of Fluorescence-Guided Surgery With Photodynamic Therapy for the Treatment of Cancer
He, J., Yang, L., Yi, W., Fan, W., Wen, Y., Miao, X., & Xiong, L. (2017) · Molecular Imaging · doi:10.1177/1536012117722911 · Cited by 54
Hirschberg, H., Sun, C., Tromberg, B. J., Yeh, A. T., & Madsen, S. J. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-9161-7 · Cited by 53
Critical Role of ABCG2 in ALA-Photodynamic Diagnosis and Therapy of Human Brain Tumor
Ishikawa, T., Kajimoto, Y., Inoue, Y., Ikegami, Y., & Kuroiwa, T. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.008 · Cited by 52
Comparative study on the ALA photodynamic effects of human glioma and meningioma cells
Tsai, J., Hsiao, Y., Teng, L., Chen, C., & Kao, M. (1999) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1999)24:4<296::aid-lsm7>3.0.co;2-f · Cited by 52
The Hydroxypyridinone Iron Chelator CP94 Can Enhance PpIX‐induced PDT of Cultured Human Glioma Cells
Blake, E., & Curnow, A. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2010.00770.x · Cited by 51
Li, F., Cheng, Y.-X., Lu, J.-Y., Hu, R., Wan, Q., & Feng, H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23228 · Cited by 50
Photodynamic therapy mediated immune therapy of brain tumors
Hirschberg, H., Berg, K., & Peng, Q. (2018) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2018.31 · Cited by 50
Tétard, M.-C., Vermandel, M., Leroy, H., Leroux, B., Maurage, C., Lejeune, J., Mordon, S. R., & Reyns, N. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.07.169 · Cited by 43
ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia
Fisher, C., Niu, C. J., Foltz, W. D., Chen, Y., Sidorova‐Darmos, E., Eubanks, J. H., & Lilge, L. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181654 · Cited by 43
Hefti, M., Albert, I., & Luginbuehl, V. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0857-9 · Cited by 42
Tang, X., Wu, J., Ben-lan, L., Cui, S., Liu, H., Yu, R., Shen, X., Wang, T., & Xia, W. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.017 · Cited by 42
ALA- and ALA-ester-mediated Photodynamic Therapy of Human Glioma Spheroids
Hirschberg, H., Sun, C., Tromberg, B. J., & Madsen, S. J. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015784926550 · Cited by 37
Ahn, P. H., Finlay, J. C., Gallagher‐Colombo, S. M., Quon, H., O’Malley, B. W., Weinstein, G. S., Chalian, A. A., Malloy, K. M., Sollecito, T. P., Greenberg, M. S., et al. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.10.015 · Cited by 35
Self-citationSURG-25INTERSTITIAL PHOTODYNAMIC THERAPY OF DE-NOVO GLIOBLASTOMA MULTIFORME WHO IV
Schwartz, C., Rühm, A., Tonn, J., Kreth, S., & Kreth, F.-W. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov235.25 · Cited by 34
A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment
Dupont, C., Mordon, S. R., Deleporte, P., Reyns, N., & Vermandel, M. (2017) · Future Oncology · doi:10.2217/fon-2017-0261 · Cited by 33
Chen, X., Wang, C., Teng, L., Liu, Y., Chen, X., Yang, G., Wang, L., Liu, H., Liu, Z., Zhang, D., et al. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.819993 · Cited by 32
Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
Reznik, E., Smith, A. W., Taube, S., Mann, J. M., Yondorf, M. Z., Parashar, B., & Wernicke, A. G. (2017) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000406 · Cited by 31
Automatic interstitial photodynamic therapy planning via convex optimization
Yassine, A., Kingsford, W., Xu, Y., Cassidy, J. A., Lilge, L. D., & Betz, V. (2018) · Biomedical Optics Express · doi:10.1364/boe.9.000898 · Cited by 30
Lawrence, J. E., Steele, C. J., Rovin, R., Belton, R. J., & Winn, R. J. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2012-x · Cited by 29
Davies, N., & Wilson, B. C. (2007) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2007.06.002 · Cited by 27
Interstitial photodynamic therapy and glioblastoma: Light fractionation in a preclinical model
Leroy, H., Vermandel, M., Dewalle, A. S., Leroux, B., Maurage, C., Duhamel, A., Mordon, S. R., & Reyns, N. (2016) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22620 · Cited by 22
Wei, Y., Xu, H., Tian, D., Wu, L., Zhang, S., Wang, L., Ji, B., Zhu, X., Okechi, H., Liu, G., et al. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1421-6 · Cited by 19
Parameter-finding studies of photodynamic therapy for approval in Japan and the USA
Kawase, Y., & Iseki, H. (2013) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2013.03.001 · Cited by 16
Set-up of the first pilot study on intraopertive 5-ALA PDT: INDYGO trial
Vermandel, M., Dupont, C., Quidet, M., Lecomte, F., LeRhun, E., Mordon, S. R., Betrouni, N., & Reyns, N. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.01.048 · Cited by 6
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy
Deng, X., Shao, Z., & Zhao, Y. (2021) · Advanced Science · doi:10.1002/advs.202002504 · Cited by 590
Light Sources and Dosimetry Techniques for Photodynamic Therapy
Kim, M. M., & Darafsheh, A. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13219 · Cited by 454
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Metadata
- Authors
- Mahmoudi, K., Garvey, K. L., Bouras, A., Cramer, G., Stepp, H., Jesu Raj, J. G., Bozec, D., Busch, T. M., & Hadjipanayis, C. G.
- Venue
- Journal of Neuro-Oncology
- Published
- 2019-01-18
- Volume
- 141
- Issue
- 3
- Pages
- 595-607
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W2910056710
- Cited by
- 292
- References
- 93
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.